Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
China
Beijing Cancer Hospital, Beijing, Beijing Municipality Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei